FR901483, a Novel Immunosuppressant Isolated from Cladobotryum sp. No. 11231 Taxonomy of the Producing Organism, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
スポンサーリンク
概要
- 論文の詳細を見る
- 1996-01-25
著者
-
OKUHARA Masakuni
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Sakamoto K
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Sakamoto K
Fujisawa Pharmaceutical Co. Ltd. Ibaraki Jpn
-
SAKAMOTO KAZUTOSHI
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
NAKANISHI TOMOKO
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
ABE FUMIE
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Tsujii Eisaku
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Tsujii E
Laboratory Of Antiviral Research Infectious Disease Research Exploratory Research Laboratories Fujis
-
SHIGEMATSU Nobuharu
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
-
Yamashita Michio
Fermentation Development Laboratories. Fujisawa Pharmaceutical Co. Ltd.
-
Yamashita Michio
Fermentation Development Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Nakanishi Tomoko
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Nakanishi Tomoko
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd
-
Abe Fumie
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
YAMASHITA Michio
Fementation Devearch Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
IZUMI Shizue
Product Development Division, Fujisawa Pharmaceutical Co. Ltd.
-
Fujie Akihiko
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Okuhara M
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Okuhara Masakuni
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Shigematsu Nobuharu
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Izumi Shizue
Product Development Division Fujisawa Pharmaceutical Co. Ltd.
-
Sakamoto Kazutoshi
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Shigematsu Nobuharu
Exploratory Research Division Astellas Research Technologies
関連論文
- In Vitro and in Vivo Inhibitory Effects of Disodium Cromoglycate on Influenza Virus Infection(Pharmacology)
- Tachykinin Antagonists Screening from Microbial Origin
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : I. Taxonomy of the Producing Organism, Fermentation, Islation and Physico-chemical Properties
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) II. Biological Activities in Animal Models
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) I. Taxonomy, Fermentation, Isolation and Biological Activities
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 II. In Vitro Property and Mode of Action
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : II. In Vitro and In Vivo Activities
- Total Synthesis of WS9326A, a Potent Tachykinin Antagonist from Streptomyces violaceoniger
- FR227673 and FR190293, Novel Antifungal Lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616
- FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : I. Taxonomy, Fermentation, and Biological Properties
- FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : II. Biological Properties and Model of Action
- New Antitumor Substances, FR901463, FR901464 and FR901465 II. Activities against Experimental Tumors in Mice and Mechanism of Action
- New Antitumor Substances, FR901464 and FR901465 I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- Action of FR901228, a Novel Antitumor Bicyclic Depsipeptide Produced by Chromobacterium violaceum No. 968, on Ha-ras Transformed NIH3T3 Cells
- Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904
- FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573
- FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : II. In Vitro and In Vivo Antifungal Activity
- FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243 : III. Structure Determination
- FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties
- FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR198248, a New Anti-influenza Agent isolated from Aspergillus terreus No.13830 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- Cycloaddition Reactions of a 3-(1,3-Butadienyl)cephalosporin and Antibacterial Activity of New Cephem Derivatives
- Structure-activity Relationships of Cephalosporins Having a (Dimethylisoxazolidinio)vinyl Moiety Their 3-Position
- FR901483, a Novel Immunosuppressant Isolated from Cladobotryum sp. No. 11231 Taxonomy of the Producing Organism, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- A New Assay Method for Immunosuppressants with a Tacrolimus (FK506)-Like Mode of Action
- FR901724,a Novel Anti-human Immunodeficiency Virus (HIV) Peptide Produced by Streptomyces, Shows Synergistic Antiviral Activities with HIV Protease Inhibitor and 2', 3'-Dideoxynucleosides
- FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : II. Isolation and Structure Elucidation
- Oxidative Activities of Heterologously Expressed CYP107B1 and CYP105D1 in Whole-Cell Biotransformation Using Streptomyces lividans TK24(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
- The Novel Gluconeogenesis Inhibitors FR225659 and FR225656 from Helicomyces sp. No. 19353 : III. Structure Determination
- New Anti-influenza Agents, FR198248 and Its Derivatives : II. Characterization of FR198248, Its Related Compounds and Some Derivatives
- FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : II. Biological Properties
- FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation
- WA8242A_1, A_1 and B, Novel Secretory Phospholipase A_1 Inhibitors Produced by Streptomyces violaceusniger I. Taxonomy, Production and Purification
- FR225659-binding Proteins : Identification as Serine/Threonine Protein Phosphatase PP1 and PP2A Using High-performance Affinity Beads
- WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens I. Taxonomy, Production, Purification and Biological Properties
- WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production Purification and Structure Elucidation
- Plasma Cholesterol Reducing Effect of FR129169, a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor, in the Rat
- WS75624 A and B, New Endothelin Converting Enzyme Inhibitors Isolated from Saccharothrix sp.No.75624 I.Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- WF14861, a New Cathepsins B and L Inhibitor Produced by Collectotrichum sp. II. Biological Properties
- WA8242A_1, A_2 and B, Novel Secretary Phospholipase A_2 Inhibitors Produced by streptomyces violaceusinger III. Structure Elucidation and Total Synthesis of WA8242B
- WA8242A_1, A_2 and B, Novel Secrtory Phospholipase A_2 Inhibitors Produced by Streptomyces violaceusniger II. Biological Properties
- Cloning and Heterologous Expression of the Antibiotic Peptide (ABP) Genes from Rhizopus oligosporus NBRC 8631
- The Promoter Activity of Isovaleryl-CoA Dehydrogenase-Encoding Gene (ivdA) from Aspergillus oryzae Is Strictly Repressed by Glutamic Acid
- Aflatoxin non-productivity of Aspergillus oryzae caused by loss of function in the aflJ gene product(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Biological and Pharmacological Properties of Highly Selective New Endothelin Converting Enzyme Inhibitor WS79089B Isolated from Streptosporangium roseum No.79089
- Acceleration of Recovery from Mitomycin C-induced Leukopenia by FK-565
- Gene Silencing by RNA Interference in the Koji Mold Aspergillus oryzae
- WS75624 A and B, New Endothelin Converting Enzyme Inhibitors Isolated from Saccharothrix sp.No.75624 II.Structure Elucidation of WS75624 A and B
- Cloning and expression of the FR901379 acylase gene from Streptomyces sd. no. 6907
- Anti-herpes virus activity of polyether antibiotic CP-44161 in vivo
- Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161
- Screening and characterization of microorganisms with FR901379 acylase activity
- Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392
- Bioconversion of AS1387392 : bioconversion studies involving Amycolatopsis azurea JCM 3275
- Bioconversion of AS1387392 : screening and characterization of actinomycetes that convert AS1387392 to AS1429716